Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?

<i>Background and Objectives</i>: There is no consensus regarding the optimal therapy sequence in stage II and III bladder cancer. The study aimed to evaluate the long-term oncologic outcomes in patients with bladder cancer after a multimodality approach. <i>Materials and methods&l...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Oana Gabriela Trifanescu, Laurentia Nicoleta Gales, Mihai Andrei Paun, Natalia Motas, Serban Andrei Marinescu, Ion Virtosu, Raluca Alexandra Trifanescu, Mirela Gherghe, Liviu Bilteanu, Camelia Cristina Diaconu, Rodica Maricela Anghel
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	bladder cancer multimodality treatment chemoradiotherapy neoadjuvant chemotherapy
Online Access:	https://www.mdpi.com/1648-9144/59/1/50